SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lynda Grine, Lien Dejager, Claude Libert, Roosmarijn E. Vandenbroucke, An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17, Cytokine & Growth Factor Reviews, 2015, 26, 1, 25

    CrossRef

  2. 2
    Junfeng Lu, Shibin Zhang, Yali Liu, Xiaofei Du, Shan Ren, Hua Zhang, Lina Ma, Yue Chen, Xinyue Chen, Chengli Shen, Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA, Liver International, 2015, 35, 6
  3. 3
    Xiaopan Wu, Weimei Shi, Jia Wu, Xilin Zhu, Kangmei Chen, Sujun Zheng, Zhuo Li, Zhongping Duan, Hui Li, Ying Liu, A functional polymorphism in ADAR1 gene affects HBsAg seroclearance both spontaneously and interferon induced, Liver International, 2014, 34, 10
  4. 4
    V. Nguyen, P. K. Tan, A.-J. Greenup, A. Glass, S. Davison, D. Samarasinghe, S. Holdaway, S. I. Strasser, U. Chatterjee, K. Jackson, S. A. Locarnini, M. T. Levy, Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  5. 5
    Teng Zeng, Hua Xu, Jun-Ying Liu, Yu Lei, Shan Zhong, Zhi Zhou, Entecavir plus adefovir combination therapy versus lamivudine add-on adefovir for lamivudine-resistant chronic hepatitis B: A meta-analysis, The Journal of Clinical Pharmacology, 2014, 54, 9
  6. 6
    Il-Hyun Park, Young-Chan Kwon, Wang-Shick Ryu, Byung-Yoon Ahn, Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L, Antiviral Research, 2014, 104, 118

    CrossRef

  7. 7
    Yuecheng Yu, Jinlin Hou, Masao Omata, Yue Wang, Lanjuan Li, Loss of HBsAg and antiviral treatment: from basics to clinical significance, Hepatology International, 2014, 8, 1, 39

    CrossRef

  8. 8
    Zhao H. Hou, Qiu J. Han, Cai Zhang, Zhi G. Tian, Jian Zhang, miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes, Liver International, 2014, 34, 1
  9. 9
    Y. He, X. Ye, P. Tiollais, J. Zhang, J. Zhang, J. Liu, Y. Xie, Selection of HBV preS1-binding penta-peptides by phage display, Acta Biochimica et Biophysica Sinica, 2014, 46, 8, 691

    CrossRef

  10. 10
    Jinhong Chang, Fang Guo, Xuesen Zhao, Ju-Tao Guo, Therapeutic strategies for a functional cure of chronic hepatitis B virus infection, Acta Pharmaceutica Sinica B, 2014, 4, 4, 248

    CrossRef

  11. 11
    Phunchai Charatcharoenwitthaya, Teerha Piratvisuth, Baseline and On-treatment Predictors of Chronic Hepatitis B Patients Receiving Pegylated Interferon Therapy in Asia, Current Hepatitis Reports, 2013, 12, 3, 165

    CrossRef

  12. 12
    Z. Huang, Z. Zhao, Y. Zheng, L. Peng, C. Lin, H. Deng, Z. Gao, Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study, Journal of Viral Hepatitis, 2013, 20,
  13. 13
    Zhen Huan Cao, Li Na Ma, Hong Wei Zhang, Ya Li Liu, Xin Yue Chen, Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion, Journal of Digestive Diseases, 2013, 14, 8
  14. 14
    Jieliang Chen, Min Wu, Xiaonan Zhang, Wen Zhang, Zhanqing Zhang, Lixiang Chen, Jing He, Ye Zheng, Cuncun Chen, Fan Wang, Yunwen Hu, Xiaohui Zhou, Cong Wang, Yang Xu, Mengji Lu, Zhenghong Yuan, Hepatitis B virus polymerase impairs interferon-α–induced STA T activation through inhibition of importin-α5 and protein kinase C-δ, Hepatology, 2013, 57, 2
  15. 15
    Claudia A. Couto, Cynthia Levy, Carol J. Morris, Mary Hill, Maria de Medina, Mark R. Sanborn, Gavin A. Cloherty, Eugene R. Schiff, Paul Martin, High Frequency of Genotype D and Spontaneous Hepatitis B Virus Genomic Mutations Among Haitians in a Multiethnic North American Population, Journal of Clinical Gastroenterology, 2013, 47, 1, 83

    CrossRef

  16. 16
    Meirong Wang, Ning Qiu, Shichun Lu, Dianrong Xiu, Jianguo Yu, Xing tai Wang, Fengmin Lu, Tong Li, Xueen Liu, Hui Zhuang, Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma, Journal of Medical Virology, 2013, 85, 2
  17. 17
    Liesbeth Ceelen, Marusya Lieveld, Ramses Forsyth, Mathieu Vinken, The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies, Hepatology International, 2013, 7, 2, 394

    CrossRef

  18. 18
    Stephanos J. Hadziyannis, Dimitrios Vassilopoulos, Emilia Hadziyannis, Antiviral Agents, 2013,

    CrossRef

  19. 19
    Eleftherios Michailidis, Karen A. Kirby, Atsuko Hachiya, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, William R. Folk, Stefan G. Sarafianos, Antiviral therapies: Focus on hepatitis B reverse transcriptase, The International Journal of Biochemistry & Cell Biology, 2012, 44, 7, 1060

    CrossRef

  20. 20
    Yanhua Zheng, Zemin Huang, Xianhua Chen, Yi Tian, Jun Tang, Yi Zhang, Xiaomin Zhang, Jijun Zhou, Qing Mao, Bing Ni, Qinghong Wang, Yuzhang Wu, Effects of Telbivudine Treatment on the Circulating CD4+T-Cell Subpopulations in Chronic Hepatitis B Patients, Mediators of Inflammation, 2012, 2012, 1

    CrossRef

  21. 21
    Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee, Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study, Scandinavian Journal of Gastroenterology, 2012, 47, 8-9, 1048

    CrossRef

  22. 22
    Xiaopan Wu, Zhenhui Xin, Xilin Zhu, Liping Pan, Zhuo Li, Hui Li, Ying Liu, Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese, Antiviral Research, 2012, 94, 3, 272

    CrossRef

  23. 23
    Xinyue Chen, Zhenhuan Cao, Yali Liu, Hongwei Zhang, Yonghong Zhang, Lina Ma, Yi Jin, Haibin Yu, Bing Ma, Yanhong Zheng, Hao Wu, Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog, Journal of Gastroenterology and Hepatology, 2012, 27, 3
  24. 24
    Ashley L. St. John, Cheryl Y. Chan, Herman F. Staats, Kam W. Leong, Soman N. Abraham, Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes, Nature Materials, 2012, 11, 3, 250

    CrossRef

  25. 25
    Jinhong Chang, Timothy M. Block, Ju-Tao Guo, The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy, Antiviral Research, 2012, 96, 3, 405

    CrossRef

  26. 26
    Rami Moucari, Raymond Sayegh, Patrick Marcellin, Update on the Role of Quantitative HBsAg and HBeAg Monitoring during Peginterferon Therapy, Current Hepatitis Reports, 2012, 11, 2, 75

    CrossRef

  27. 27
    Fanli Meng, Jiefei Wang, Jian Ge, Xiaopeng Fan, Bing Wang, Liyan Han, Tatiana Kisseleva, YongHan Paik, David A. Brenner, Kai Wang, Alteration of Interferon-α/β Receptors in Chronic Hepatitis B Patients, Journal of Clinical Immunology, 2011, 31, 3, 521

    CrossRef

  28. 28
    Yu Chen, Xuefen Li, Bo Ye, Xianzhi Yang, Wei Wu, Baode Chen, Xiaoping Pan, Hongcui Cao, Lanjuan Li, Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B, Antiviral Research, 2011, 91, 1, 23

    CrossRef

  29. 29
    Vincenza Calvaruso, Antonio Craxì, Fibrosis in chronic viral hepatitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 219

    CrossRef

  30. 30
    W. Graham Cooksley, Hepatitis B Genotypes: Role of Testing in Clinical Practice, Current Hepatitis Reports, 2011, 10, 2, 79

    CrossRef

  31. 31
    Hatef Massoumi, Paul Martin, Hui-Hui Tan, Management of chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2011, 23, 8, 642

    CrossRef

  32. You have free access to this content32
    Stephanos J. Hadziyannis, Milestones and perspectives in viral hepatitis B, Liver International, 2011, 31,
  33. 33
    Zhihui Chen, Jie Cao, Xiaoling Liao, Jinshan Ke, Shiying Zhu, Ping Zhao, Zhongtian Qi, Plasmids Enriched with CpG Motifs Activate Human Peripheral Blood Mononuclear CellsIn Vitroand Enhance Th-1 Immune Responses to Hepatitis B Surface Antigen in Mice, Viral Immunology, 2011, 24, 3, 199

    CrossRef

  34. 34
    Tatyana A. Shamliyan, James R. Johnson, Roderick MacDonald, Aasma Shaukat, Jian-Min Yuan, Robert L. Kane, Timothy J. Wilt, Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection, Journal of General Internal Medicine, 2011, 26, 3, 326

    CrossRef

  35. 35
    Ding-Shinn Chen, Pei-Jer Chen, Tropical Infectious Diseases: Principles, Pathogens and Practice, 2011,

    CrossRef

  36. 36
    Bin Wu, Te Li, Huafeng Chen, Jinfang Shen, Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis, Value in Health, 2010, 13, 5
  37. 37
    You-hua Xie, Ran Hong, Wei Liu, Jing Liu, Jian-wei Zhai, Development of novel therapeutics for chronic hepatitis B, Virologica Sinica, 2010, 25, 4, 294

    CrossRef

  38. 38
    W. G. E. Cooksley, Do we need to determine viral genotype in treating chronic hepatitis B?, Journal of Viral Hepatitis, 2010, 17, 9
  39. 39
    Chiaki Okuse, Hiroshi Yotsuyanagi, Norie Yamada, Masaru Okamoto, Hiroki Ikeda, Minoru Kobayashi, Yasunobu Fukuda, Hideaki Takahashi, Yoshihiko Nagase, Yuka Suzuki, Kotaro Matsunaga, Toshiya Ishii, Nobuyuki Matsumoto, Kazuhiko Koike, Michihiro Suzuki, Fumio Itoh, Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B, Hepatology Research, 2010, 40, 5
  40. 40
    Y. Xie, J. Zhai, Q. Deng, P. Tiollais, Y. Wang, M. Zhao, Entry of hepatitis B virus: Mechanism and new therapeutic target, Pathologie Biologie, 2010, 58, 4, 301

    CrossRef

  41. 41
    Maurizia Rossana Brunetto, Filippo Oliveri, Piero Colombatto, Francesco Moriconi, Pietro Ciccorossi, Barbara Coco, Veronica Romagnoli, Beatrice Cherubini, Giovanna Moscato, Anna Maria Maina, Daniela Cavallone, Ferruccio Bonino, Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers, Gastroenterology, 2010, 139, 2, 483

    CrossRef

  42. 42
    Jinchao Han, Xiaoben Pan, Yan Gao, Lai Weil, Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein, Virus Research, 2010, 150, 1-2, 129

    CrossRef

  43. 43
    Hui Chen, Lu-Wen Wang, Yan-Qing Huang, Zuo-Jiong Gong, Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo, International Journal of Molecular Sciences, 2010, 11, 9, 3501

    CrossRef

  44. 44
    Nicole E. Pagliaccetti, Esther N. Chu, Christopher R. Bolen, Steven H. Kleinstein, Michael D. Robek, Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities, Virology, 2010, 401, 2, 197

    CrossRef

  45. 45
    R. B. Takkenberg, C. J. Weegink, H. L. Zaaijer, H. W. Reesink, New developments in antiviral therapy for chronic hepatitis B, Vox Sanguinis, 2010, 98, 4
  46. You have free access to this content46
    Rami Moucari, Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks, Journal of Gastroenterology and Hepatology, 2010, 25, 9
  47. 47
    P. Spagnolo, S. Zeuzem, L. Richeldi, R. M. Du Bois, The complex interrelationships between chronic lung and liver disease: a review, Journal of Viral Hepatitis, 2010, 17, 6
  48. 48
    Ding-Shinn Chen, Toward elimination and eradication of hepatitis B, Journal of Gastroenterology and Hepatology, 2010, 25, 1
  49. 49
    Rami Moucari, Olivier Lada, Patrick Marcellin, Chronic hepatitis B: back to the future with HBsAg, Expert Review of Anti-infective Therapy, 2009, 7, 6, 633

    CrossRef

  50. 50
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 11
  51. 51
    Hui-Hui Tan, Paul Martin, Current treatment of chronic HBV infection: A North American perspective, Current Hepatitis Reports, 2009, 8, 4, 148

    CrossRef

  52. 52
    Robert P. Perrillo, Hepatitis B surface antigen quantification as a current-day paradox: Obtaining the gold in the face of diminishing returns, Hepatology, 2009, 49, 4
  53. 53
    Fu-Sheng Wang, Zheng Zhang, Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus, Expert Review of Gastroenterology & Hepatology, 2009, 3, 5, 499

    CrossRef

  54. 54
    Gillian M. Keating, Peginterferon-α-2a (40 kD), Drugs, 2009, 69, 18, 2633

    CrossRef

  55. 55
    Amir Shlomai, Yoav Lubelsky, Ofir Har-Noy, Yosef Shaul, The “Trojan horse” model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector, Biochemical and Biophysical Research Communications, 2009, 390, 3, 619

    CrossRef